Maze Therapeutics, Inc. (MAZE): Narxning prognoz qilingan daromadga nisbati

Maze Therapeutics, Inc. (MAZE) kompaniyasining korporativ logotipi

Pompe kasalligi uchun klinikadan oldingi tadqiqotlar zanjirining dinamikasi va naqd pul sarflash sur'ati Maze Therapeutics Inc (MAZE) kompaniyasining muvaffaqiyatini belgilaydi. Forward P/S koeffitsiyenti bozarning ushbu omillarga bo'lgan reaksiyasini aks ettiradi, bunda 95.80 darajasi eng so'nggi qiymatlarni qamrab oladi. Genetika sohasidagi ilmiy yetakchi maqomi ishonchni saqlab qolsa-da, kelishuvning tartibga soluvchi to'sig'i kompaniyani o'z aktivlarini rivojlantirish uchun yangi litsenziyalash hamkorlarini qidirishga majbur qilmoqda.

Maze Therapeutics, Inc. - MAZE Bozor kapitallashuvining kelajakdagi daromadga nisbati (davr: 14.08.2025 - 17.11.2026)

Maze Therapeutics Inc (MAZE) kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning har tomonlama tahlili:Maze Therapeutics Corp MAZE
Maze Therapeutics Corp tomonidan chiqariladigan mahsulotlar

Maze Therapeutics Inc (MAZE) metabolik patologiyalarni nishonga oluvchi genetik platformalar segmentida mustahkam mavqega ega. Forward P/S baholashini tahlil qilish orqali investor joriy bozor kapitalizatsiyasining prognoz qilingan savdolarga nisbatini ko'rishi mumkin, bu esa choraklik hisobotlardagi kechikishlarni bartaraf etadi. Ushbu ko'rsatkichning pasayishi aktivning qadriyatidan past baholanganini yoki likvidlik risklarining ortayotganini anglatishi mumkin. Maze Therapeutics Inc (MAZE) uchun ushbu nisbat kelajakdagi pipeline tasdiqlanishi va Sanofi dan keladigan to'lovlar qiymatiga oid bozor konsensusini aks ettiradi.

Maze Therapeutics Inc (MAZE) raqobatchilari

Forvard P/S multiplikatori TEM (Tempus Labs)|Qiagen N.V. - Narxning prognoz qilingan daromadga nisbati|IONS - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati repligen.com|RNA: Forvard P/S multiplikatori|CRISPR Therapeutics Inc (CRSP) - Forvard P/S multiplikatori|WGS (GeneDx Holdings) - Forvard P/S multiplikatori|RARE: Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori BEAM (Beam Therapeutics Corp)|SRPT: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori TWST (Twist Bioscience Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati 10x Genomics Corp (TXG)|intelliatx.com - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Stoke STOK|biolifesolutions.com (BLFS) - Narxning prognoz qilingan daromadga nisbati|WVE - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|SION (Sionna Therapeutics, Inc.) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Prime Medicine Corp (PRME)|Forvard P/S multiplikatori TSHA|Forvard P/S multiplikatori uniQure N.V. (QURE)|Narxning prognoz qilingan daromadga nisbati MeiraGTx Holdings plc MGTX|RGNX: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Solid Biosciences Inc - Forvard P/S multiplikatori|OCGN - Forvard P/S multiplikatori|PACB: Forvard P/S multiplikatori|BNTC - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Design Therapeutics, Inc.|RCKT: Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori FDMT (4D Molecular Therapeutics, Inc.)|Lexeo Therapeutics, Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Korro Bio, Inc. KRRO|EDIT: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|SLN - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati ProQR Therapeutics (PRQR)|CDXS (Codexis Bio) - Forvard narx/daromad multiplikatori|Sangamo Therapeutics Inc. (SGMO) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Nautilus Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Metagenomi Therapeutics MGX|Narxning prognoz qilingan daromadga nisbati Precision BioSciences (DTIL)|GBIO - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori BOLD (Boundless Bio, Inc)|XCUR - Forvard narx/daromad multiplikatori|IMNN - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Phio Pharmaceuticals Corp|MBIO: Forvard P/S multiplikatori|TransCode (RNAZ) - Forvard P/S multiplikatori|BNGO (Bionano) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Applied DNA Sciences, Inc. APDN|Forvard P/S multiplikatori BLUE|ImmunoPrecise Antibodies Ltd - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Omega Therapeutics OMGA|OMIC: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|RGLS: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx SYRS (Syros Pharmaceuticals, Inc.)|Telesis Bio, Inc. (TBIO) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati TCON (TRACON)|Narxning prognoz qilingan daromadga nisbati Unity Biotechnology, Inc.